Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
NCT06935864 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-04-20
Summary
The current study is to assess the prognostic value of Krüppel-like factors 4 and 7 in bone tumors, and its role in the disease progression.
Conditions
- Osteosarcoma in Children
- Ewing Sarcoma of Bone or Soft Tissue
Interventions
- DIAGNOSTIC_TEST
-
KLF factor (4 and 7)
Immunohistochemical staining of 4 um sections prepared from paraffin blocks using KLF factor (4 and 7) by automated immunostaining using the streptavidin-biotin technique.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Fatma S E Ebeid · Faculty of Medicine Ain Shams University
Eligibility
- Min Age
- 1 Month
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-16
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
Countries
- Egypt
Study Locations
More Related Trials
-
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
NCT02199938 ·Status: TERMINATED
-
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 ·Status: COMPLETED
-
The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence
NCT04758455 ·Status: UNKNOWN ·Phase: NA
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
Genetic Characterisation of High-grade Paediatric Osteosarcomas
NCT00223184 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
NCT01374672 ·Status: COMPLETED
-
Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
NCT04893356 ·Status: ACTIVE_NOT_RECRUITING
-
Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI)
NCT03759704 ·Status: WITHDRAWN
-
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
NCT00898469 ·Status: COMPLETED
-
Study of Blood Samples From Patients With Osteosarcoma
NCT00954473 ·Status: COMPLETED
-
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
NCT00579930 ·Status: COMPLETED
-
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01807143 ·Status: COMPLETED
-
Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
NCT06851221 ·Status: COMPLETED ·Phase: NA
-
Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms
NCT05553067 ·Status: COMPLETED
-
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
NCT06068075 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Expressiona and Diagnostic Potential of miRNAs in NSCLC
NCT05815407 ·Status: COMPLETED
-
Biomarkers in Samples From Young Patients With Neuroblastoma
NCT01358604 ·Status: COMPLETED
-
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
NCT05782985 ·Status: UNKNOWN
-
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
NCT06759714 ·Status: RECRUITING
-
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)
NCT03125707 ·Status: RECRUITING
-
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
NCT00364715 ·Status: COMPLETED
-
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046 ·Status: COMPLETED
-
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
NCT00899275 ·Status: COMPLETED
-
Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience
NCT02665676 ·Status: UNKNOWN